Jennifer Jarrett


Jennifer Jarrett has served as a member of our board of directors since September 2018. Since March 2017, Ms. Jarrett has served as Chief Operating Officer and Chief Financial Officer of Arcus Biosciences, a biotechnology company developing next generation cancer immunotherapies. Prior to Arcus, Ms. Jarrett was Chief Financial Officer of Medivation, which was acquired by Pfizer in 2016. Before Medivation, Ms. Jarrett spent 20 years in investment banking, most recently at Citigroup where she ran the firm’s west coast life sciences investment banking practice, and prior to that at Credit Suisse and Donaldson, Lufkin & Jenrette. In 2014, she was named one of the Most Influential Women in Bay Area Business by the San Francisco Business Times. Ms. Jarrett currently serves on the board of directors of Arena Pharmaceuticals and Audentes Therapeutics. Ms. Jarrett received a Bachelor of Arts in economics from Dartmouth College and her M.B.A. from the Stanford Graduate School of Business.